U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.376G>A (p.Asp126Asn) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000631273.8

Allele description [Variation Report for NM_000551.4(VHL):c.376G>A (p.Asp126Asn)]

NM_000551.4(VHL):c.376G>A (p.Asp126Asn)

Genes:
LOC107303340:3p25 von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase Alu-mediated recombination region [Gene]
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.376G>A (p.Asp126Asn)
Other names:
NM_000551.4(VHL):c.376G>A; p.Asp126Asn
HGVS:
  • NC_000003.12:g.10146549G>A
  • NG_008212.3:g.9915G>A
  • NG_046756.1:g.4311G>A
  • NM_000551.4:c.376G>AMANE SELECT
  • NM_001354723.2:c.*18-3238G>A
  • NM_198156.3:c.341-3238G>A
  • NP_000542.1:p.Asp126Asn
  • NP_000542.1:p.Asp126Asn
  • LRG_322t1:c.376G>A
  • LRG_322:g.9915G>A
  • LRG_322p1:p.Asp126Asn
  • NC_000003.11:g.10188233G>A
  • NM_000551.3:c.376G>A
  • p.D126N
Protein change:
D126N; ASP126ASN
Links:
OMIM: 608537.0028; dbSNP: rs104893831
NCBI 1000 Genomes Browser:
rs104893831
Molecular consequence:
  • NM_001354723.2:c.*18-3238G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_198156.3:c.341-3238G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000551.4:c.376G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chuvash polycythemia
Synonyms:
POLYCYTHEMIA, VHL-DEPENDENT; Erythrocytosis, familial, 2
Identifiers:
MONDO: MONDO:0009892; MedGen: C1837915; Orphanet: 238557; OMIM: 263400
Name:
Von Hippel-Lindau syndrome (VHLS)
Synonyms:
VHL syndrome; Von Hippel-Lindau
Identifiers:
MONDO: MONDO:0008667; MedGen: C0019562; Orphanet: 892; OMIM: 193300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000752301Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 20, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function.

Briston T, Stephen JM, Thomas LW, Esposito C, Chung YL, Syafruddin SE, Turmaine M, Maddalena LA, Greef B, Szabadkai G, Maxwell PH, Vanharanta S, Ashcroft M.

Front Oncol. 2018;8:388. doi: 10.3389/fonc.2018.00388. Erratum in: Front Oncol. 2021 Sep 23;11:740273. doi: 10.3389/fonc.2021.740273.

PubMed [citation]
PMID:
30338240
PMCID:
PMC6180203

Early-onset and severe pulmonary arterial hypertension due to a novel compound heterozygous association of rare VHL mutations: A case report and review of existing data.

Chomette L, Migeotte I, Dewachter C, Vachiery JL, Smits G, Bondue A.

Pulm Circ. 2022 Apr;12(2):e12052. doi: 10.1002/pul2.12052.

PubMed [citation]
PMID:
35734542
PMCID:
PMC9190294
See all PubMed Citations (4)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000752301.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 126 of the VHL protein (p.Asp126Asn). This variant is present in population databases (rs104893831, gnomAD 0.004%). This missense change has been observed in individual(s) with autosomal recessive erythrocytosis and pulmonary hypertension, and/or polycythemia and pulmonary hypertension (PMID: 21454469, 30338240, 35734542). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant has been reported in individual(s) with clinical features of autosomal dominant von Hippel-Lindau syndrome, as well as in unaffected individuals (Invitae; external communication); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 141044). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt VHL protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects VHL function (PMID: 21454469). In summary, this variant has been classified as Pathogenic for autosomal recessive erythrocytosis. However, the risk conferred by this variant is uncertain for autosomal dominant von Hippel-Lindau syndrome.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 19, 2025